Arexis Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$10.1M
Arexis General Information
Description
Operator of a pharmaceutical company intended to develop metabolic and inflammatory disease therapeutics. The company's research is biology-driven with proprietary technology and a focus on the development of pharmaceuticals for the treatment of lipid malabsorption, diabetes, atopic dermatitis (inflammatory skin disease) and rheumatoid arthritis, enabling doctors with novel therapies to easily treat patients.
Contact Information
Primary Office
- Arvid Wallgrens Backe
- 413 46 Gothenburg
- Sweden
+46 031-749 00 00
Arexis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 22-Aug-2005 | $10.1M | 000.00 | 000.00 | Completed | Clinical Trials - General |
| 3. Early Stage VC | 01-Jul-2003 | 00.000 | 000.00 | Completed | Startup | |
| 2. Early Stage VC | 30-May-2001 | $4.64M | $4.64M | Completed | Startup | |
| 1. Early Stage VC | Completed | Startup |
Arexis Patents
Arexis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10625180-B2 | Manufacturing method | Active | 31-Oct-2014 | 00000000000 | 00 |
| US-20170333812-A1 | An improved manufacturing method | Active | 31-Oct-2014 | 00000000000 | |
| US-9499590-B2 | Antibodies against and methods for producing vaccines for respiratory syncytial virus | Active | 02-Feb-2009 | 0000000000 | 000 |
| US-20150125479-A1 | Antibodies against and methods for producing vaccines for respiratory syncytial virus | Active | 02-Feb-2009 | 0000000000 | 0 |
| US-8852608-B2 | Antibodies against and methods for producing vaccines for respiratory syncytial virus | Active | 02-Feb-2009 | C07K14/005 | 000 |
Arexis Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Lennart Hansson Ph.D | Chief Executive Officer |
Arexis Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| 3i Group | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Industrifonden | Venture Capital | Minority | 000 0000 | 000000 0 | |
| InnovationsKapital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Kreos Capital | Lender/Debt Provider | Minority | 000 0000 | 000000 0 | |
| Skandinaviska Enskilda Banken | Investment Bank | Minority | 000 0000 | 000000 0 |